Literature DB >> 15297571

Tetanic depression is overcome by tonic adenosine A(2A) receptor facilitation of L-type Ca(2+) influx into rat motor nerve terminals.

Laura Oliveira1, M Alexandrina Timóteo, Paulo Correia-de-Sá.   

Abstract

Motor nerve terminals possess multiple voltage-sensitive calcium channels operating acetylcholine (ACh) release. In this study, we investigated whether facilitation of neuromuscular transmission by adenosine generated during neuronal firing was operated by Ca(2+) influx via 'prevalent' P-type or via the recruitment of 'silent' L-type channels. The release of [(3)H]ACh from rat phrenic nerve endings decreased upon increasing the stimulation frequency of the trains (750 pulses) from 5 Hz (83 +/- 4 x 10(3) disintegrations per minute per gram (d.p.m. g(-1)); n = 11) to 50 Hz (30 +/- 3 x 10(3) d.p.m. g(-1); n = 5). The P-type Ca(2+) channel blocker, omega-agatoxin IVA (100 nm) reduced (by 40 +/- 10%; n = 6) the release of [(3)H]ACh evoked by 50-Hz trains, while nifedipine (1 microM, an L-type blocker) was inactive. Tetanic depression was overcome (88 +/- 6 x 10(3) d.p.m. g(-1); n = 12) by stimulating the phrenic nerve with 50-Hz bursts (five bursts of 150 pulses, 20 s interburst interval). In these conditions, omega-agatoxin IVA (100 nM) failed to affect transmitter release, but nifedipine (1 microM) decreased [(3)H]ACh release by 21 +/- 7% (n = 4). Inactivation of endogenous adenosine with adenosine deaminase (ADA, 0.5 U ml(-1)) reduced (by 54 +/- 8%, n = 5) the release of [(3)H]ACh evoked with 50-Hz bursts. This effect was opposite to the excitatory actions of adenosine (0.5 mm), S-(p-nitrobenzyl)-6-thioinosine (5 microM, an adenosine uptake blocker) and CGS 21680C (3 nM, a selective A(2A) receptor agonist); as the A(1) receptor agonist R-N(6)-phenylisopropyl adenosine (R-PIA, 300 nM) failed to affect the release of [(3)H]ACh, the results indicate that adenosine generated during 50-Hz bursts exerts an A(2A)-receptor-mediated tonus. The effects of ADA (0.5 U ml(-1)) and CGS 21680C (3 nm) were prevented by nifedipine (1 microM). Blocking tonic A(2A) receptor activation, with ADA (0.5 U ml(-1)) or 3,7-dimethyl-1-propargyl xanthine (10 microM, an A(2A) antagonist), recovered omega-agatoxin IVA (100 nM) inhibition and caused the loss of function of nifedipine (1 microM). Data indicate that, in addition to the predominant P-type Ca(2+) current triggering ACh release during brief tetanic trains, motoneurones possess L-type channels that may be recruited to facilitate transmitter release during high-frequency bursts. The fine-tuning control of Ca(2+) influx through P- or L-type channels is likely to be mediated by endogenous adenosine. Therefore, tonic activation of presynaptic A(2A) receptors operating Ca(2+) influx via L-type channels may contribute to overcome tetanic depression during neuronal firing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297571      PMCID: PMC1665215          DOI: 10.1113/jphysiol.2004.067595

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  56 in total

1.  Response.

Authors:  D B Wheeler; R W Tsien; A Randall
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

Review 2.  Multiple calcium channels and neuronal function.

Authors:  R J Miller
Journal:  Science       Date:  1987-01-02       Impact factor: 47.728

3.  Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve ending of the rat.

Authors:  P Correia-de-Sá; A M Sebastião; J A Ribeiro
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

4.  Evidence that the presynaptic A2a-adenosine receptor of the rat motor nerve endings is positively coupled to adenylate cyclase.

Authors:  P Correia-de-Sá; J A Ribeiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

5.  Cavbeta-subunit displacement is a key step to induce the reluctant state of P/Q calcium channels by direct G protein regulation.

Authors:  Guillaume Sandoz; Ignacio Lopez-Gonzalez; Didier Grunwald; Delphine Bichet; Xavier Altafaj; Norbert Weiss; Michel Ronjat; Alain Dupuis; Michel De Waard
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

Review 6.  Distinctive pharmacology and kinetics of cloned neuronal Ca2+ channels and their possible counterparts in mammalian CNS neurons.

Authors:  J F Zhang; A D Randall; P T Ellinor; W A Horne; W A Sather; T Tanabe; T L Schwarz; R W Tsien
Journal:  Neuropharmacology       Date:  1993-11       Impact factor: 5.250

7.  Developmental changes in rat diaphragm endplate response to repetitive stimulation.

Authors:  A R Bazzy
Journal:  Brain Res Dev Brain Res       Date:  1994-09-16

8.  P-type Ca2+ channels trigger stimulus-evoked [3H]acetylcholine release from mammalian motor endplates.

Authors:  I Wessler; D J Dooley; B Lohr
Journal:  Eur J Pharmacol       Date:  1995-05-04       Impact factor: 4.432

9.  Transmitter release and presynaptic Ca2+ currents blocked by the spider toxin omega-Aga-IVA.

Authors:  D A Protti; O D Uchitel
Journal:  Neuroreport       Date:  1993-12-13       Impact factor: 1.837

Review 10.  Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

Authors:  K A Jacobson; P J van Galen; M Williams
Journal:  J Med Chem       Date:  1992-02-07       Impact factor: 7.446

View more
  10 in total

1.  Potentiation of high voltage-activated calcium channels by 4-aminopyridine depends on subunit composition.

Authors:  Li Li; De-Pei Li; Shao-Rui Chen; Jinjun Chen; Hongzhen Hu; Hui-Lin Pan
Journal:  Mol Pharmacol       Date:  2014-09-29       Impact factor: 4.436

2.  Revealing of T-type low-voltage activated calcium channels (CaV3) in frog neuromuscular junctions.

Authors:  L F Nurullin; A N Tsentsevitsky; A I Malomouzh; E E Nikolsky
Journal:  Dokl Biol Sci       Date:  2013-05-08

3.  Modulation of Ca2+-currents by sequential and simultaneous activation of adenosine A1 and A 2A receptors in striatal projection neurons.

Authors:  O Hernández-González; T Hernández-Flores; G A Prieto; A Pérez-Burgos; M A Arias-García; E Galarraga; J Bargas
Journal:  Purinergic Signal       Date:  2013-09-07       Impact factor: 3.765

4.  Developmental Synaptic Changes at the Transient Olivocochlear-Inner Hair Cell Synapse.

Authors:  Graciela Kearney; Javier Zorrilla de San Martín; Lucas G Vattino; Ana Belén Elgoyhen; Carolina Wedemeyer; Eleonora Katz
Journal:  J Neurosci       Date:  2019-02-12       Impact factor: 6.167

Review 5.  Purinergic modulation of synaptic signalling at the neuromuscular junction.

Authors:  Keith J Todd; Richard Robitaille
Journal:  Pflugers Arch       Date:  2006-04-08       Impact factor: 3.657

6.  Deficits in endogenous adenosine formation by ecto-5'-nucleotidase/CD73 impair neuromuscular transmission and immune competence in experimental autoimmune myasthenia gravis.

Authors:  Laura Oliveira; Alexandra Correia; Ana Cristina Costa; Sónia Guerra-Gomes; Fátima Ferreirinha; Maria Teresa Magalhães-Cardoso; Manuel Vilanova; Paulo Correia-de-Sá
Journal:  Mediators Inflamm       Date:  2015-01-27       Impact factor: 4.711

Review 7.  Synaptic Homeostasis and Its Immunological Disturbance in Neuromuscular Junction Disorders.

Authors:  Masaharu Takamori
Journal:  Int J Mol Sci       Date:  2017-04-24       Impact factor: 5.923

8.  Involvement of the Voltage-Gated Calcium Channels L- P/Q- and N-Types in Synapse Elimination During Neuromuscular Junction Development.

Authors:  Neus Garcia; Pablo Hernández; Maria A Lanuza; Marta Tomàs; Víctor Cilleros-Mañé; Laia Just-Borràs; Maria Duran-Vigara; Aleksandra Polishchuk; Marta Balanyà-Segura; Josep Tomàs
Journal:  Mol Neurobiol       Date:  2022-04-27       Impact factor: 5.682

9.  Adenosine A2A receptors activation facilitates neuromuscular transmission in the pre-symptomatic phase of the SOD1(G93A) ALS mice, but not in the symptomatic phase.

Authors:  Filipe Nascimento; Paula A Pousinha; Alexandra M Correia; Rui Gomes; Ana M Sebastião; Joaquim A Ribeiro
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

10.  Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability.

Authors:  Masaharu Takamori
Journal:  Front Mol Neurosci       Date:  2020-05-28       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.